Los marcadores de superficie celular son importantes en este proceso, ya que existe una creciente demanda de ensayos de diagnóstico precisos y confiables para detectar estas enfermedades de manera temprana. Los marcadores de superficie celular, de acuerdo con los Institutos Nacionales de Salud (NIH), son cruciales para la identificación de células y el control del sistema inmunológico. También se emplean en los procesos de búsqueda de nuevos medicamentos y como indicadores de la actividad de la enfermedad.
Los linfocitos T, los linfocitos B y los linfocitos NK son los tres tipos de células que componen el mercado mundial de marcadores de superficie celular. Los linfocitos T son linfocitos específicos de antígeno que se desarrollan en el timo después de derivarse del tejido hematopoyético. A partir de esto, se denominan linfocitos dependientes del timo. Los linfocitos T auxiliares (Th), citotóxicos (Tc) y reguladores (Treg) son los tres tipos de linfocitos T. Además de tener la actividad inmunitaria antitumoral de los linfocitos T y las características de eliminación de tumores no limitantes del MHC de los linfocitos NK, los linfocitos NKT son subconjuntos de linfocitos T con características de células NK. Son células cruciales para la defensa del cuerpo contra las infecciones, la resistencia a los tumores y el equilibrio autoinmunitario.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por tipo de célula, por tipo de producto, por aplicación, por región. |
| Por tipo de célula |
|
| Por tipo de producto |
|
| Por aplicación |
|
| Por región |
|
Los linfocitos B son linfocitos derivados del tejido hematopoyético que son específicos de antígenos. Los linfocitos B se desarrollan y maduran en la médula ósea, a diferencia de los linfocitos T. Los linfocitos B son activados por antígenos y experimentan una serie de cambios, entre ellos, convertirse en blastos plasmáticos , diferenciarse en células plasmáticas, producir y secretar inmunoglobulinas (anticuerpos) y participar en la inmunidad humoral. Su función es producir anticuerpos, administrar antígenos y secretar elementos intracelulares que controlan el sistema inmunitario. Al estudiar las enfermedades autoinmunes y los trastornos del sistema inmunitario en las enfermedades, la identificación de los linfocitos B y sus subconjuntos es un indicador crucial.
El citoplasma de las células asesinas naturales contiene partículas de gran tamaño. Aunque no se conoce con exactitud el origen de las células NK, se acepta generalmente que se producen directamente en la médula ósea. Al secretar citocinas y ejercer citotoxicidad, las células NK activadas tienen efectos antivirales, antitumorales e inmunorreguladores.
Los marcadores de superficie celular son un mercado impulsado principalmente por los avances tecnológicos en la producción de anticuerpos monoclonales y la fabricación de anticuerpos específicos de células para el diagnóstico y pronóstico de enfermedades.
The Cell surface markers market reached USD 4.02 billion in 2020 and is expected to grow at a CAGR of more than 8.1% through 2029, owing to the increasing in awareness about health.
The upcoming trend in the Cell surface markers market is an opportunity for market growth.
The global Cell surface markers market registered a CAGR of 8.1% from 2022 to 2029.
Key players profiled in the report include BD Biosciences, Beckman Coulter, Inc., Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, QIAGEN N.V, Sony Biotechnology Inc, Abcam plc, Cell Signaling Technology, Inc. and Sigma-Aldrich Co. LLC.
The North America Cell surface markers market had largest market share of 41% in 2021.
Flow cytometry, PCR arrays, and antibodies are a few of the product types used to segment the market for cell surface markers. The revenue market share for antibodies in 2021 was sizable. Antibodies can be used to identify specific cell types and the proteins that are associated with them on the cell surface.
They are now an essential research tool in many disciplines, including immunology, cancer, and neurology. Additionally, thanks to improvements in antibody synthesis and conjugation technologies, it is now possible to detect cell surface markers with antibodies that are more sensitive and specific. Additionally, the market for antibodies against cell surface markers has expanded significantly as a result of the increase in chronic diseases like cancer and autoimmune diseases. The demand for this market is growing, as is its revenue, as a result of the widespread use of antibodies in the detection and treatment of cancer and other chronic diseases.
Throughout the projection period, there is expected to be a significant increase in the use of PCR arrays. PCR arrays are being used more frequently in a growing number of scientific disciplines, such as cancer biology, immunology, and neuroscience, for genetic profiling and gene expression research. In addition, the sensitivity and specificity of cutting-edge PCR array-based analysis techniques like digital PCR and qPCR have been enhanced, making them more efficient at detecting cell surface markers. Additionally, it is anticipated that the market for cell surface markers will grow as a result of the increasing focus on precision medicine and the growing demand for customised treatments.
The flow cytometry segment is anticipated to see the fastest revenue growth over the course of the forecast period. Due to the growing importance of personalised medicine and the rising demand for flow cytometry in drug discovery and development, this market is expected to grow. The state-of-the-art technique of flow cytometry allows for the simultaneous detection of multiple cell surface markers, providing researchers with a comprehensive understanding of cellular function. Demand for this subsegment of the cell surface markers market is also anticipated to rise as a result of the expanding use of flow cytometry in clinical diagnostics and drug development.
The market is divided into research, clinical, and other applications. The clinical segment is further divided into oncology and haematology, while the research segment is further divided into stem cell and immunology. Due to the increasing demand for cell surface markers in clinical research applications, the research segment is anticipated to hold the largest share in the global market for cell surface markers during the forecast period.
The drug discovery segment is also anticipated to experience significant growth during the projection period. This market is expected to grow as a result of the increased focus on personalised medicine and the expanding use of cell surface markers in drug discovery and development. Cell surface indicators are used in drug development to identify potential therapeutic targets, improve drug efficacy, and reduce the likelihood of adverse drug reactions. Additionally, the emergence of cutting-edge techniques for cell surface marker identification, such as high-throughput screening and single-cell sequencing, has increased their efficacy in drug discovery and development.
The segment for clinical applications is anticipated to have the highest CAGR during the forecast period. The growing application of cell surface markers in clinical diagnostics and the increasing significance of customised treatment are expected to drive this market's expansion. Cell surface markers provide doctors with crucial information about the patient's condition and are used in a variety of clinical diagnostics, including the diagnosis of cancer, infectious diseases, and autoimmune disorders. The sensitivity and specificity of advanced cell surface marker detection techniques, such as flow cytometry and immunohistochemistry, have also increased, making them more useful for clinical diagnosis.
[caption id="attachment_23343" align="aligncenter" width="1920"]
Geographically, the Cell surface markers market is segmented into North America, South America, Europe, APAC and MEA.
With regard to the rising demand for cell surface marker technology in the expanding clinical research sectors in China, India, and Australia, the Asia Pacific region is predicted to experience the fastest growth in the global cell surface marker market over the course of the forecast period. Europe is a significant region for the global market for cell surface markers and is anticipated to grow steadily over the forecast period.
The market for cell surface markers is dominated by North America as of the region's developed economies' robust clinical research industries. Over the course of the forecast period, North America's expanding medical research sector is expected to continue to be a key driver of the cell surface markers market there. In North America, where the majority of the industry's top players are concentrated, medical research is a significant industry. The medical research industry in North America has been elevated above other regions due to the presence of top players. The cell surface marker market in North America is likely to be significantly influenced by the region's strong cellular research community, particularly in the fields of cancer and haematology research.
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.